A study of over 450,000 NSTEMI admissions reveals that diabetics face disparities in care, with less invasive treatment ...

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

The Global Myocardial Infarction Therapeutics Market is estimated to be valued at USD 15.56 billion in 2023 and is projected to grow at a CAGR of 4.19% over the forecast period 2024-2032. Read the ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...

The following is a summary of “Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction—A Matched Case-Control Study,” published in the October ...

ed.ac.uk Myocardial injury is common in patients without acute coronary syndrome, and international guidelines recommend patients with myocardial infarction are classified by aetiology. The universal ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

The history of women being left out of heart disease research has had significant consequences on heart health care today.

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert ...

Kaare Harald Bønaa, MD, PhD, specialist in internal medicine and cardiology, senior consultant in interventional cardiology, professor emeritus in cardiovascular epidemiology and clinical director at ...

While women are thought to generally have greater protection than men against CVD due to estrogen, women have been shown to ...

Many people do not realize that there is more than one form of a heart attack, also known as a myocardial infarction. Some only involve a partial obstruction of blood flow. Heart specialists refer to ...